AAAAAA
Results: 1-25/211
Authors:
Bessler, M
Schaefer, A
Keller, P
Citation: M. Bessler et al., Paroxysmal nocturnal hemoglobinuria: Insights from recent advances in molecular biology, TR MED REV, 15(4), 2001, pp. 255-267
Authors:
Vostal, JG
Holada, K
Simak, J
Citation: Jg. Vostal et al., Expression of cellular prion protein on blood cells: Potential functions in cell physiology and pathophysiology of transmissible spongiform encephalopathy diseases, TR MED REV, 15(4), 2001, pp. 268-281
Authors:
Orton, S
Citation: S. Orton, Syphilis and blood donors: What we know, what we do not know, and what we need to know, TR MED REV, 15(4), 2001, pp. 282-291
Authors:
Foley, R
Tozer, R
Wan, YH
Citation: R. Foley et al., Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine, TR MED REV, 15(4), 2001, pp. 292-304
Authors:
Ness, PM
Shirey, RS
Weinstein, MH
King, KE
Citation: Pm. Ness et al., An animal model for delayed hemolytic transfusion reactions, TR MED REV, 15(4), 2001, pp. 305-317
Authors:
Chester, MA
Olsson, ML
Citation: Ma. Chester et Ml. Olsson, The ABO blood group gene: A locus of considerable genetic diversity, TR MED REV, 15(3), 2001, pp. 177-200
Authors:
Kleinman, S
Citation: S. Kleinman, Hepatitis G virus biology, epidemiology, and clinical manifestations: Implications for blood safety, TR MED REV, 15(3), 2001, pp. 201-212
Authors:
Strauss, RG
Citation: Rg. Strauss, Managing the anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin, TR MED REV, 15(3), 2001, pp. 213-223
Authors:
Morgenthaler, JJ
Citation: Jj. Morgenthaler, Securing viral safety for plasma derivatives, TR MED REV, 15(3), 2001, pp. 224-233
Authors:
Newman, B
Citation: B. Newman, Blood donor suitability and allogeneic whole blood donation, TR MED REV, 15(3), 2001, pp. 234-244
Authors:
Hoots, WK
Citation: Wk. Hoots, Plasma-product safety: An overview - Guest editorial, TR MED REV, 15(2), 2001, pp. 1-2
Authors:
Hoots, WK
Citation: Wk. Hoots, History of plasma-product safety, TR MED REV, 15(2), 2001, pp. 3-10
Authors:
Hoots, WK
Citation: Wk. Hoots, Safety issues affecting hemophilia products, TR MED REV, 15(2), 2001, pp. 11-19
Authors:
Hoots, WK
Abrams, C
Tankersley, D
Citation: Wk. Hoots et al., The food and drug administration's perspective on plasma safety, TR MED REV, 15(2), 2001, pp. 20-26
Authors:
Fischer, G
Hoots, WK
Abrams, C
Citation: G. Fischer et al., Viral reduction techniques: Types and purpose, TR MED REV, 15(2), 2001, pp. 27-39
Authors:
Liss, A
Citation: A. Liss, One manufacturer's approach to using nucleic acid testing for enhanced plasma-product safety, TR MED REV, 15(2), 2001, pp. 40-44
Authors:
Hoots, WK
Abrams, C
Tankersley, D
Citation: Wk. Hoots et al., The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety, TR MED REV, 15(2), 2001, pp. 45-59
Authors:
Tinmouth, A
Chin-Yee, I
Citation: A. Tinmouth et I. Chin-yee, The clinical consequences of the red cell storage lesion, TR MED REV, 15(2), 2001, pp. 91-107
Authors:
Conry-Cantilena, C
Citation: C. Conry-cantilena, Phlebotomy, blood donation, and hereditary hemochromatosis, TR MED REV, 15(2), 2001, pp. 136-143
Authors:
Escolar, G
Galan, AM
Mazzara, R
Castillo, R
Ordinas, A
Citation: G. Escolar et al., Measurement of platelet interactions with subendothelial substrata: Relevance to transfusion medicine, TR MED REV, 15(2), 2001, pp. 144-156
Authors:
Boyce, N
Citation: N. Boyce, Is there a place for hyperimmune globulins in the treatment of refractory infections?, TR MED REV, 15(2), 2001, pp. 157-168
Authors:
Geiger, TL
Jyothi, MD
Citation: Tl. Geiger et Md. Jyothi, Development and application of receptor-modified T lymphocytes for adoptive immunotherapy, TR MED REV, 15(1), 2001, pp. 21-34
Authors:
Siegel, DL
Citation: Dl. Siegel, Research and clinical applications of antibody phage display in transfusion medicine, TR MED REV, 15(1), 2001, pp. 35-52
Authors:
Yazdanbakhsh, K
Citation: K. Yazdanbakhsh, Molecular mechanisms underlying defective expression of blood group antigens, TR MED REV, 15(1), 2001, pp. 53-66
Authors:
Sandler, SG
Citation: Sg. Sandler, Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin, TR MED REV, 15(1), 2001, pp. 67-76